Soluble Fas affects erythropoiesis in vitro and acts as a potential predictor of erythropoiesis-stimulating agent therapy in patients with chronic kidney disease

Serum soluble Fas (sFas) levels are associated with erythropoietin (Epo) hyporesponsiveness in patients with chronic kidney disease (CKD). Whether sFas could predict the need for erythropoiesis-stimulating agent (ESA) usage and its influence in erythropoiesis remain unclear. We evaluated the relatio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Physiol Renal Physiol
Autors principals: Chiloff, Daniela Mendes, de Almeida, Danilo Candido, Dalboni, Maria A., Canziani, Maria Eugênia, George, Sunil K., Morsi, Alshaimaa Mahmoud, El-Akabawy, Nadia, Porada, Christopher D., Durao, Marcelino Souza, Zarjou, Abolfazl, Almeida-Porada, Graca, Goes, Miguel Angelo
Format: Artigo
Idioma:Inglês
Publicat: American Physiological Society 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7474254/
https://ncbi.nlm.nih.gov/pubmed/32003597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00433.2019
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars